Grifols (GRFS) Gains from Sales and Divestitures (2010 - 2024)
Grifols (GRFS) reported Gains from Sales and Divestitures of $2.26 million for the year ended Dec 31, 2025, up 111.5% from $1.07 million a year earlier.
Powered by 
Analysis
Grifols (GRFS) Gains from Sales and Divestitures (2010 - 2024) Analysis & Trends
Dating back to the year ended Dec 31, 2009, Grifols' Gains from Sales and Divestitures record includes 17 years.
- Gains from Sales and Divestitures has a five-year compound annual growth rate of 13.2% (years ended Dec 2020 to Dec 2025).
- Five-year annual Gains from Sales and Divestitures spans a low of -$1.77 million in the year ended Dec 31, 2022 and a high of $7.53 million in the year ended Dec 31, 2023.
- According to Business Quant data, Gains from Sales and Divestitures came in at $1.07 million in the year ended Dec 31, 2024 (-85.8%), $7.53 million in the year ended Dec 31, 2023, -$1.77 million in the year ended Dec 31, 2022 and $1.37 million in the year ended Dec 31, 2021 (+12.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Grifols | 4.97 Bn | 4.59 Bn | 3.33 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 1.07 Mn |
| Dec 31, 2022 | -1.77 Mn |
| Dec 31, 2016 | -4.38 Mn |
| Sep 30, 2016 | 285,743.23 |
| Dec 31, 2015 | 1.32 Mn |
| Sep 30, 2015 | 4.79 Mn |
| Jun 30, 2015 | 764,757.76 |
| Mar 31, 2015 | 581,863.73 |
| Dec 31, 2014 | 8.90 Mn |
| Sep 30, 2014 | 2.52 Mn |
| Jun 30, 2014 | 2.19 Mn |
| Mar 31, 2014 | -2.60 Mn |
| Dec 31, 2013 | 1.10 Mn |
| Sep 30, 2013 | 276,933.07 |
| Jun 30, 2013 | 1.25 Mn |
| Mar 31, 2013 | 3.59 Mn |
| Dec 31, 2012 | 15.29 Mn |
| Sep 30, 2012 | -175,085.35 |
| Jun 30, 2012 | 1.01 Mn |
| Mar 31, 2012 | 135,065.50 |
API Access
Grifols Gains from Sales and Divestitures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=GRFS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gains-from-sales-and-divestitures", "ticker": "GRFS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=GRFS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();